Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
Published version of a preprint
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
The eIF4F complex regulates the cap-dependent mRNA translation process. It is becoming increasingly evident that aberrant activity of this complex is observed in many cancers, leading to the selective synthesis of proteins involved in tumor growth and metastasis. The selective translation of cellular mRNAs controlled by this complex also contributes to resistance to cancer treatments, and downregulation of the eIF4F complex components can restore sensitivity to various cancer therapies. Here, we review the contribution of the eIF4F complex to tumorigenesis, with a focus on its role in chemoresistance as well as the promising use of new small-molecule inhibitors of the complex, including flavaglines/rocaglates, hippuristanol, and pateamine A. Clin Cancer Res; 23(1); 21–25. ©2016 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Translational control by 5′-untranslated regions of eukaryotic mRNAs
Hinnebusch, A. G., Ivanov, I. P., & Sonenberg, N. (2016) · Science · doi:10.1126/science.aad9868 · Cited by 1,079
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799 · cited 2×
“Clin Cancer Res; 23(1) January 1, 2017 Clinical Cancer Research 22”
BackgroundRNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635 · cited 1×
“ThemRNAs that require eIF4A for their translationwere characterized using transcriptome-scale ribosome footprinting (6).”
MethodMoerke, N. J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M. Y., Fahmy, A., Gross, J. D., Degterev, A., Yuan, J., Chorev, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.046 · Cited by 572
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
Furic, L., Rong, L., Larsson, O., Koumakpayi, I. H., Yoshida, K., Brueschke, A., Petroulakis, E., Robichaud, N., Pollak, M., Gaboury, L. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005320107 · Cited by 519
Dissecting eIF4E action in tumorigenesis
Wendel, H.-G., Silva, R. L. A., Malina, A., Mills, J. R., Zhu, H., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., et al. (2007) · Genes & Development · doi:10.1101/gad.1604407 · Cited by 487 · cited 1×
“Strong evidence links eIF4E phosphorylation with tumourigenesis, invasion and metastatic progression in cells and in mice models (7-10).”
BackgroundNew frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.27 · Cited by 378 · cited 4×
“The eIF4F complex is located at the convergence of several cell signaling pathways involved in carcinogenesis, including the PI(3)K/AKT/mTOR pathway and the RAS/RAF/MEK/ERK/MNK MAPK pathway (Fig.”
InfluentialeIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Boussemart, L., Malka-Mahieu, H., Girault, I., Allard, D., Hemmingsson, O., Tomasic, G., Thomas, M., Basmadjian, C., Ribeiro, N., Thuaud, F., et al. (2014) · Nature · doi:10.1038/nature13572 · Cited by 371
Self-citationTargeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2789 · Cited by 367 · cited 1×
“, MYC, CCDN1, ODC1, VEGF, FGF2) or more generally cancer-related genes (2).”
Cited by
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
“Pharmacological and genetic studies have validated eIF4F as an oncogenic node and targetable vulnerability in cancer cells (Malka-Mahieu et al., 2017).”
Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
Cerezo, M., Guemiri, R., Druillennec, S., Girault, I., Malka-Mahieu, H., Shen, S., Allard, D., Martineau, S., Welsch, C., Agoussi, S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0217-1 · Cited by 254
Self-citationEukaryotic translation initiation factors as promising targets in cancer therapy
Hao, P., Yu, J., Ward, R. J., Liu, Y., Qiao, H., An, S., & Xu, T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00607-9 · Cited by 142
The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation
Sun, L.-Y., Wang, W., Han, C., Huang, W., Sun, Y., Fang, K., Zeng, Z., Yang, Q., Pan, Q., Chen, T., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.033 · Cited by 134
The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
Amorim, I. S., Lach, G., & Gkogkas, C. G. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00561 · Cited by 104
Metadata
- Authors
- Malka-Mahieu, H., Newman, M., Désaubry, L., Robert, C., & Vagner, S.
- Affiliations
- Université Paris-Sud (FR)
- Centre National de la Recherche Scientifique (FR)
- Venue
- Clinical Cancer Research
- Published
- 2017-01-01
- Volume
- 23
- Issue
- 1
- Pages
- 21-25
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2544544592
- Cited by
- 105
- References
- 52
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 15 · 2020: 17 · 2019: 12 · 2018: 12 · 2017: 1
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- eIF4F, cap-dependent translation, cancer therapy resistance, chemoresistance, small molecule inhibitors, flavaglines, rocaglates, pateamine A, carcinogenesis, metastasis, translation initiation
- MeSH terms
- Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Humans, Neoplasms, Protein Biosynthesis, Signal Transduction, Gene Expression Regulation, Neoplastic, Drug Resistance, Neoplasm, Eukaryotic Initiation Factor-4F, Multiprotein Complexes, Translational Research, Biomedical, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-14-2362
- The paper
- Malka-Mahieu, H., Newman, M., Désaubry, L., Robert, C., & Vagner, S. (2017). Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-14-2362
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.